Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 4 BMI and mortality in patients with heart failure

Published byVictoria Molina Piñeiro Modified over 5 years ago

Similar presentations

Presentation on theme: "Figure 4 BMI and mortality in patients with heart failure"— Presentation transcript:

1 Figure 4 BMI and mortality in patients with heart failure
Figure 4 | BMI and mortality in patients with heart failure. Meta-analysis of six studies (n = 22,807) on the effect of BMI on cardiovascular mortality, all-cause mortality, and hospitalizations for heart failure. Reproduced from Sharma, A. et al. Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure. Am. J. Cardiol. 115, 1428–1434 (2015), with permission from Elsevier. Reproduced from Sharma, A. et al. Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure. Am. J. Cardiol. 115, 1428–1434 (2015), with permission from Elsevier Lavie, C. J. et al. (2017) Management of cardiovascular diseases in patients with obesity Nat. Rev. Cardiol. doi: /nrcardio

Download ppt "Figure 4 BMI and mortality in patients with heart failure"

Similar presentations

Distribution of metabolic syndrome (MS) components by age and gender Zhao D, et al. Am J Cardiol 2007;100:835– 839.

Distribution of metabolic syndrome (MS) components by age and gender Zhao D, et al. Am J Cardiol 2007;100:835– 839.
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Figure 10 Assessment of myocardial fibrosis

Figure 10 Assessment of myocardial fibrosis
Reproduced with permission from Yancy, C. W. et al. 2017

Reproduced with permission from Yancy, C. W. et al. 2017
Figure 5 BMI and cardiorespiratory fitness levels

Figure 5 BMI and cardiorespiratory fitness levels
Figure 8 Implanted devices for the management of heart failure

Figure 8 Implanted devices for the management of heart failure
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Figure 5 Two approaches to therapeutic genome editing

Figure 5 Two approaches to therapeutic genome editing
Figure 2 Pathological specimens showing the most common reasons for bioprosthetic valve failure Figure 2 | Pathological specimens showing the most common.

Figure 2 Pathological specimens showing the most common reasons for bioprosthetic valve failure Figure 2 | Pathological specimens showing the most common.
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Figure 3 Global rates of sodium, fruit, and vegetable intake

Figure 3 Global rates of sodium, fruit, and vegetable intake
Figure 2 Size categorization of airborne pollutants

Figure 2 Size categorization of airborne pollutants
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Figure 2 Three-year survival rates on the basis of body composition

Figure 2 Three-year survival rates on the basis of body composition
Figure 7 European Society of Cardiology 2016

Figure 7 European Society of Cardiology 2016
Figure 2 Physical activity and obesity levels by WHO-designated region and sex Figure 2 | Physical activity and obesity levels by WHO-designated region.

Figure 2 Physical activity and obesity levels by WHO-designated region and sex Figure 2 | Physical activity and obesity levels by WHO-designated region.

Similar presentations

Ads by Google